PCR & Real-time PCR Molecular Diagnostics Market to Reach US$ 16.5 Billion by 2035, Driven by Precision Medicine and Rising Demand for Advanced Molecular Testing

The global PCR & Real-time PCR Molecular Diagnostics Market is poised for steady expansion over the next decade as healthcare providers increasingly rely on molecular testing for rapid disease detection, precision medicine, and personalized treatment strategies. According to the latest market analysis, the industry was valued at US$ 9.7 billion in 2024 and is expected to reach US$ 16.5 billion by 2035, registering a CAGR of 5.1% from 2025 to 2035.

The market continues to benefit from the growing prevalence of infectious diseases, increasing global cancer burden, advancements in molecular biology, and expanding investments in healthcare infrastructure. PCR and real-time PCR technologies have become indispensable tools for detecting pathogens, identifying genetic mutations, monitoring treatment response, and supporting clinical research.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=79197

Key Drivers of Market Growth

One of the primary factors driving market growth is the increasing incidence of infectious diseases across the globe. Viral outbreaks, antimicrobial resistance, and emerging pathogens continue to create strong demand for rapid molecular diagnostic solutions capable of detecting infections with high sensitivity and specificity.

The rising global burden of cancer is another major growth catalyst. PCR-based diagnostics are widely used to identify genetic mutations such as EGFR, KRAS, and BRCA1/2, helping physicians select personalized treatment options and monitor disease progression.

Growing adoption of precision medicine is further accelerating market expansion. Modern healthcare increasingly focuses on individualized therapies based on genetic profiles, making PCR and real-time PCR essential tools for biomarker identification, companion diagnostics, and treatment optimization.

Continuous investments in genomics research, biotechnology innovation, and healthcare infrastructure are also supporting widespread adoption of advanced molecular diagnostic technologies across hospitals, research institutions, and diagnostic laboratories.

Key Players and Industry Leaders

The competitive landscape remains highly dynamic, with leading manufacturers investing heavily in product innovation, automation, digital PCR technologies, and strategic collaborations.

Major companies operating in the global PCR & real-time PCR molecular diagnostics market include:

• F. Hoffmann-La Roche Ltd
• Abbott
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company (BD)
• bioMérieux
• DiaSorin S.p.A.
• Hologic, Inc.
• SD Biosensor, Inc.
• QIAGEN N.V.
• QuidelOrtho
• Siemens Healthineers AG
• Bio-Rad Laboratories, Inc.
• Agilent Technologies, Inc.
• Danaher Corporation

These companies continue expanding their product portfolios through technological advancements, regulatory approvals, acquisitions, and partnerships to strengthen their global market presence.

Key Trends for the Future

Several emerging trends are expected to shape the future of the PCR & real-time PCR molecular diagnostics market.

Digital PCR (dPCR) is rapidly gaining popularity because it provides superior sensitivity and absolute nucleic acid quantification, making it highly suitable for oncology diagnostics and liquid biopsy applications.

Point-of-care PCR systems are also becoming increasingly important by enabling rapid molecular testing outside traditional laboratory settings. Compact and automated PCR instruments are improving accessibility in emergency care, rural healthcare facilities, and decentralized laboratories.

Artificial intelligence integration into molecular diagnostics is another significant trend. AI-powered software assists laboratories in data interpretation, quality control, workflow optimization, and automated reporting, improving overall diagnostic efficiency.

Additionally, laboratories are adopting environmentally sustainable consumables and energy-efficient laboratory equipment to reduce operational costs and environmental impact.

New Opportunities and Challenges

Expanding molecular diagnostics in developing economies presents substantial opportunities for market participants. Increasing healthcare investments, improved laboratory infrastructure, and greater awareness regarding early disease detection are creating new growth avenues across Asia Pacific, Latin America, and the Middle East.

The growing application of PCR technologies in food safety testing, forensic science, environmental monitoring, agricultural biotechnology, and veterinary diagnostics further broadens market potential.

However, several challenges continue to influence industry growth. High equipment costs, limited access to advanced molecular laboratories in low-income regions, reimbursement uncertainties, and the need for highly trained laboratory professionals remain key barriers to widespread adoption.

Maintaining standardized testing protocols and ensuring regulatory compliance across global markets also require continuous investment from manufacturers.

Buy this Premium Research Report and secure exclusive access to insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=79197<ype=S

Market Trends & Innovations

Automation has become one of the strongest trends influencing molecular diagnostics. Clinical laboratories increasingly utilize automated sample preparation, nucleic acid extraction, and PCR workflows to improve efficiency while minimizing manual errors.

Multiplex PCR technologies are gaining widespread acceptance because they enable simultaneous detection of multiple pathogens or biomarkers within a single test, reducing turnaround time and laboratory costs.

Manufacturers are also developing highly sensitive assay kits capable of detecting extremely low concentrations of DNA and RNA, enhancing diagnostic accuracy for oncology, infectious diseases, and inherited disorders.

Recent product launches and collaborations continue strengthening technological innovation. Companies are introducing advanced digital PCR systems, multiplex assays, and integrated molecular diagnostic platforms designed to improve workflow efficiency while expanding clinical applications.

Future Outlook

The future of the PCR & real-time PCR molecular diagnostics market remains highly promising as healthcare systems continue prioritizing early diagnosis, personalized medicine, and precision healthcare.

North America is expected to maintain its market leadership due to advanced healthcare infrastructure, significant research investments, and strong adoption of innovative molecular diagnostic technologies. Meanwhile, Asia Pacific is projected to witness substantial growth owing to expanding healthcare expenditure, increasing disease prevalence, and growing biotechnology industries.

Reagents and consumables will continue generating the largest revenue share because they are required for every PCR testing procedure, ensuring recurring demand across hospitals, diagnostic laboratories, and research organizations.

As molecular diagnostics become increasingly integrated into routine clinical practice, PCR technologies will remain fundamental to disease detection, genomic research, and personalized healthcare worldwide.

Market Segmentation

By Product Type

• Instruments, Reagents and Consumables, Software and Services

By Technology

• Conventional PCR, Real-time PCR

By Application

• Oncology
• Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer, Others
• Infectious Diseases
• Sexual Health Diseases, Blood-borne Virus, Respiratory Infections, Healthcare-associated Infections, Others
• Genetic Testing, Neurological Disease, Others

By End-user

• Hospitals & Clinics, Diagnostic Laboratories, Others

By Region

• North America, Europe, Asia Pacific, Latin America , Middle East & Africa

Important FAQs with Answers

Q1. How large was the PCR & Real-time PCR molecular diagnostics market in 2024?

The global market was valued at US$ 9.7 billion in 2024.

Q2. What is the projected market size by 2035?

The market is expected to reach US$ 16.5 billion by the end of 2035.

Q3. What is the expected CAGR during the forecast period?

The market is forecast to expand at a CAGR of 5.1% from 2025 to 2035.

Q4. What are the major factors driving market growth?

Key growth drivers include the rising prevalence of infectious diseases and cancer, increasing demand for precision medicine, expanding healthcare infrastructure, and ongoing investments in molecular diagnostics research and development.

Q5. Which region dominated the market in 2024?

North America held the largest market share, accounting for 43.3% of global revenue in 2024.

Q6. Which product segment generated the highest revenue?

The Reagents and Consumables segment led the market with a 53.8% revenue share in 2024.

Q7. Who are the leading companies operating in the market?

Leading companies include F. Hoffmann-La Roche Ltd, Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Bio-Rad Laboratories, Siemens Healthineers AG, Hologic, Danaher Corporation, and bioMérieux.

More Related Reports -

Companion Diagnostics Market: https://www.transparencymarketresearch.com/companion-diagnostics-market.html

Cell Line Authentication and Characterization Tests Market: https://www.transparencymarketresearch.com/cell-line-authentication-and-characterization-tests-market.html

Dengue Testing Market: https://www.transparencymarketresearch.com/dengue-testing-market.html

Liver Cancer Diagnostics Market: https://www.transparencymarketresearch.com/liver-cancer-diagnostics-market.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analyzed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact:

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com

Sales Inquiries: sales@transparencymarketresearch.com